Literature DB >> 21654666

Is silence still golden? Mapping the RNAi patent landscape.

Per Lundin1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21654666     DOI： 10.1038/nbt.1885

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  On firm ground: IP protection of therapeutic nanoparticles.

Authors:  Paul Burgess; Peter Barton Hutt; Omid C Farokhzad; Robert Langer; Scott Minick; Stephen Zale
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

2.  Drug giants turn their backs on RNA interference.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

3.  Drug research. Roche exits RNAi field, cuts 4800 jobs.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2010-11-26       Impact factor: 47.728

4.  Public biotech 2006 - the numbers.

Authors:  Riku Lähteenmäki; Stacy Lawrence
Journal:  Nat Biotechnol       Date:  2007-07       Impact factor: 54.908

5.  Teaming up to tackle RNAi delivery challenge.

Authors:  Dan Jones
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

6.  Public biotech 2008--the numbers.

Authors:  Brady Huggett; John Hodgson; Riku Lähteenmäki
Journal:  Nat Biotechnol       Date:  2009-08       Impact factor: 54.908

7.  The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.

Authors:  Bonnie W McLeod; Mark L Hayman; Angela L Purcell; Joshua S Marcus; Erich Veitenheimer
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

8.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

9.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

10.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962
  10 in total
  6 in total

1.  The Reporting Items for Patent Landscapes statement.

Authors:  James A Smith; Zeeshaan Arshad; Anthony Trippe; Gary S Collins; David A Brindley; Andrew J Carr
Journal:  Nat Biotechnol       Date:  2018-11-09       Impact factor: 54.908

Review 2.  mRNA-based therapeutics--developing a new class of drugs.

Authors:  Ugur Sahin; Katalin Karikó; Özlem Türeci
Journal:  Nat Rev Drug Discov       Date:  2014-09-19       Impact factor: 84.694

3.  TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Sergey Nechaev; Anna Kozlowska; Wang Zhang; Yong Liu; Claudia M Kowolik; Piotr Swiderski; John J Rossi; Stephen Forman; Sumanta Pal; Ravi Bhatia; Andrew Raubitschek; Hua Yu; Marcin Kortylewski
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

4.  International Collaboration and Spatial Dynamics of US Patenting in Central and Eastern Europe 1981-2010.

Authors:  Balázs Lengyel; Mariann Leskó
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Green Tea Catechin Dramatically Promotes RNAi Mediated by Low-Molecular-Weight Polymers.

Authors:  Wanwan Shen; Qingwei Wang; Yang Shen; Xiao Gao; Lei Li; Yang Yan; Hui Wang; Yiyun Cheng
Journal:  ACS Cent Sci       Date:  2018-09-19       Impact factor: 14.553

Review 6.  Applications of RNA Interference in Schistosomiasis: Gene Function Identification and Development of New Therapies.

Authors:  Tiago Campos Pereira; Cláudia Carolina Silva Evangelista; Gustavo Borges; Eliana Maria Zanotti-Magalhães; Luiz Augusto Magalhães; Iscia Lopes-Cendes
Journal:  ISRN Parasitol       Date:  2012-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.